The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the […]
December 2013 Life Science Industry Research Reports
Ranirestat (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the […]
Atrasentan (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the […]
Optina (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the […]
Eylea (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the […]
Avastin (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the […]
Lucentis (Microvascular Complications of Diabetes) – Forecast and Market Analysis to 2022
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the […]
PharmaPoint: Microvascular Complications of Diabetes – Current and Future Players
GlobalData has released its pharma report, “PharmaPoint: Microvascular Complications of Diabetes Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Microvascular Complications of Diabetes Market. The […]
Primary Biliary Cirrhosis – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Primary Biliary Cirrhosis Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Primary Biliary Cirrhosis, complete with latest updates, and special features on late-stage and […]
Tachycardia (Tachyarrhythmias) – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Tachycardia (Tachyarrhythmias) Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Tachycardia (Tachyarrhythmias), complete with latest updates, and special features on late-stage and discontinued projects. […]
Stay In Touch